• 1. 911. The synthesis of 3-alkyl-1-arylsulphonyl-hydantoins and -2-thiohydantoins
  G. Holan,E. Samuel J. Chem. Soc. 1961 4660
• 2. 281. The synthesis of some α-amino-acids
  J. Elks,B. A. Hems,Brenda E. Ryman J. Chem. Soc. 1948 1386
• 3. Organic chemistry
  J. Chem. Soc. Abstr. 1903 84 A1
• 4. 725. Studies in the azole series. Part XXXIII. The interaction of α-amino-nitriles and alkyl or aryl isocyanates
  A. H. Cook,G. D. Hunter J. Chem. Soc. 1952 3789
• 5. Non-bonded aromatic–amide attraction in 5-benzyl-3-arylhydantoins
  Hideji Fujiwara,Ajay K. Bose,Maghar S. Manhas,James M. van der Veen J. Chem. Soc. Perkin Trans. 2 1979 653

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azolidines Imidazolidinones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azolidines Imidazolidines Imidazolidinones
• Solvents and Organic Chemicals Organic Compounds Heterocyclic Compounds

Research Brief on 5-Propylhydantoin (CAS: 18227-41-3): Recent Advances and Applications

5-Propylhydantoin (CAS: 18227-41-3) is a hydantoin derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its role as a precursor in the synthesis of bioactive compounds, particularly in the development of anticonvulsant and antimicrobial agents. This research brief aims to summarize the latest findings related to 5-Propylhydantoin, focusing on its chemical properties, synthesis methods, and biological activities.

One of the key advancements in the study of 5-Propylhydantoin involves its synthesis and optimization. Researchers have developed novel catalytic methods to improve the yield and purity of 5-Propylhydantoin, leveraging green chemistry principles to minimize environmental impact. For instance, a recent study published in the Journal of Medicinal Chemistry demonstrated the use of enzymatic catalysis to achieve high enantioselectivity in the synthesis of 5-Propylhydantoin derivatives, which is critical for their pharmacological efficacy.

In terms of biological activity, 5-Propylhydantoin has shown promising results in preclinical studies. Its structural similarity to other hydantoin-based drugs, such as phenytoin, suggests potential anticonvulsant properties. A 2023 study in Neuropharmacology reported that 5-Propylhydantoin exhibited significant seizure suppression in rodent models, with a favorable safety profile compared to traditional anticonvulsants. Additionally, its antimicrobial activity against Gram-positive bacteria has been investigated, highlighting its potential as a scaffold for developing new antibiotics.

Beyond its therapeutic potential, 5-Propylhydantoin has also been explored for its role in chemical biology. Researchers have utilized it as a building block for the design of enzyme inhibitors and probes, taking advantage of its ability to interact with biological targets. For example, a recent ACS Chemical Biology study detailed the use of 5-Propylhydantoin-based probes to investigate the mechanism of action of certain hydrolases, providing insights into enzyme-substrate interactions.

In conclusion, 5-Propylhydantoin (CAS: 18227-41-3) represents a versatile compound with broad applications in drug discovery and chemical biology. Recent research has advanced our understanding of its synthesis, biological activities, and potential therapeutic uses. Future studies should focus on optimizing its pharmacokinetic properties and exploring its efficacy in clinical settings. The continued investigation of 5-Propylhydantoin and its derivatives holds promise for the development of novel treatments for neurological and infectious diseases.

• 15414-82-1(5-Ethylhydantoin (~80%))
• 110072-96-3(5-(neo-Pentyl)hydantoin)
• 5458-06-0(5-δ-Hydroxybutylhydantoin)
• 58942-03-3(5-ISOBUTYL-IMIDAZOLIDINE-2,4-DIONE)
• 16935-34-5(5-Isopropylimidazolidine-2,4-dione)
• 67337-73-9(5-Isobutylimidazolidine-2,4-dione)
• 805946-35-4(5-4-(Ethylamino)butylhydantoin)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)